Please login to the form below
AMNOG
This page shows the latest AMNOG news and features for those working in and with pharma, biotech and healthcare.
Germany planning to table pricing reforms 'by the summer'
The report proposes reforms to the AMNOG (Pharmaceutical Market Restructuring Act), which include the introduction of rebates after a sales threshold is met and suggests that only five or six new ... German Minister of Health Hermann Gröhe has suggested
Latest news
-
Novo pulls Tresiba from Europe’s biggest market
The price negotiations between pharma and German payers has since 2011 become much harder for the industry as the new AMNOG law has allowed the country's health technology assessors to
-
Celgene’s psoriasis pill gives ‘no added benefit’ to patients
AMNOG). This law is supervised by a ruling body called G-BA – this body will now make a final decision on the extent of the added benefit, and decide on what
-
German pharma market to edge up to $65bn by 2020
In 2011, the German government initiated a law on the reorganisation of the pharmaceutical market, Arzneimittelmarkt-Neuordnungsgesetz (AMNOG), with the aim of slowing down the growing drug expenditure within the public ... Joshua Owide, GlobalData's
-
German drug cost containment system 'aids data transparency'
This type of information is largely available in AMNOG documents, albeit only partly in English. ... AMNOG also shows that clinical study reports can be nearly fully published without damaging pharmaceutical companies.”.
-
A baptism of fire for Europe's new health commissioner
Many countries have also been failing to pay their drug bills, including more recently Greece and Italy, with other countries such as Germany introducing draconian new policies such as the AMNOG
More from news
Approximately 3 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Rare diseases: meeting the challenge
SKC’s white paper ‘Orphan Drugs in Germany - lessons learned from AMNOG, best and worst practices and strategic implications’ (Kirchmann et al, 2017) offers pharma manufacturers a few pointers for successful
-
Market access in Europe: balancing access and affordability
Germany: overhaul of AMNOG and extended price freeze. The German Parliament has been working for several months on the Gesetz zur Stärkung der Arzneimittelversorgung in der GKV (AM-VSG; Act to ... Strengthen Pharmaceutical Supply in the Statutory Health
-
Cost containment and the German market
In 2011 the Pharmaceutical Market Restructuring Act (AMNOG) was adopted - a strong regulating and much-discussed instrument for the moderation of price increases caused by recently approved products.
-
The price is right?
The passing of Arzneimittelmarktneuordnungsgesetz (AMNOG), the Pharmaceutical Market Reorganisation Act, in 2010 introduced new regulations around the reimbursement of drugs within the German healthcare system.
-
Making savings from European drugs budgets
AMNOG. Germany is the largest pharma market in Europe and one of the strongest economies in the Eurozone, but it too has had to make deep cuts into its medicines bill. ... This has been done through the 2011 law known as AMNOG, which changed the way
More from intelligence
Approximately 5 fully matching, plus 12 partially matching documents found.
Latest appointments
-
Extension for head of Germany’s VFA
She has led the industry voice during an unsettled time for pharma in Germany with many companies critical of the AMNOG system of drug reimbursement introduced in 2010, which has seen
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Oncology drugs under AMNOG
The AMNOG early benefit assessment process in Germany is now over three years old and as tweaks are made to regulations and manufacturers gain more familiarity with the process we look ... With the advent of the AMNOG assessment, manufacturers face new
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
